ACRO Biomedical , Ltd. Profit Margin

ACRO Biomedical , Ltd.'s profit margin stands at -149.34% as of June 2026. That compares with -203.12% in the prior-year period — up 26.5% year over year. That is below the sector sector average of 13.2%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

ACRO Biomedical , Ltd. reported -149.34% in profit margin versus -203.12% a year earlier — a 26.5% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

ACRO Biomedical , Ltd. sits lower the its sector benchmark (13.2%) with a profit margin of -149.34%. That is roughly 1231.5% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of -149.34% for ACRO Biomedical , Ltd. means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how ACRO Biomedical , Ltd.'s profit margin evolved across reporting periods, while the comparison chart places 6748.TWO next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.